Compare Fajar Surya Wisesa Tbk. (FASW) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fajar Surya Wisesa Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Fajar Surya Wisesa Tbk. trades at Rp5,275 (market cap 16.99T), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Fajar Surya Wisesa Tbk. is far larger — about 162.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| FASW | SCPI | |
|---|---|---|
Market Cap | 16.99T | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fajar Surya Wisesa Tbk.
PT Fajar Surya Wisesa Tbk (the Company) was established based on Notarial Deed No. 20 dated June 13, 1987 of Lenny Budiman, S.H., notary in Jakarta.
Read more on FASW →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
